Difference between revisions of "Part:BBa K792003:Design"
Manugimenez (Talk | contribs) |
(→References) |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 6: | Line 6: | ||
===Design Notes=== | ===Design Notes=== | ||
| − | Sequence obtained by retro-translation | + | Sequence obtained by retro-translation. Codon and mRNA-secondary structure optimized for yeast. |
| − | + | ||
| − | + | ||
===Source=== | ===Source=== | ||
HIV TAT penetratin | HIV TAT penetratin | ||
| + | |||
Characterisation of cell-penetrating peptide-mediated peptide delivery [Jones et al 2005] | Characterisation of cell-penetrating peptide-mediated peptide delivery [Jones et al 2005] | ||
===References=== | ===References=== | ||
| + | |||
| + | Jones, S. W., R. Christison, et al. (2005). "Characterisation of cell-penetrating peptide-mediated peptide delivery." Br J Pharmacol 145(8): 1093-1102. | ||
Latest revision as of 19:21, 25 September 2012
Import enhancer - HIV TAT penetratin (trojan peptide)
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
Sequence obtained by retro-translation. Codon and mRNA-secondary structure optimized for yeast.
Source
HIV TAT penetratin
Characterisation of cell-penetrating peptide-mediated peptide delivery [Jones et al 2005]
References
Jones, S. W., R. Christison, et al. (2005). "Characterisation of cell-penetrating peptide-mediated peptide delivery." Br J Pharmacol 145(8): 1093-1102.